Horizon Therapeutics Public Ltd Co Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Horizon Therapeutics Public Ltd Co quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q2 2023.
  • Horizon Therapeutics Public Ltd Co Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $8.18M, a 115% increase year-over-year.
  • Horizon Therapeutics Public Ltd Co Income Tax Expense (Benefit) for the twelve months ending June 30, 2023 was $5.86M.
  • Horizon Therapeutics Public Ltd Co annual Income Tax Expense (Benefit) for 2022 was $5.45M.
  • Horizon Therapeutics Public Ltd Co annual Income Tax Expense (Benefit) for 2021 was -$71.7M, a 705% decline from 2020.
  • Horizon Therapeutics Public Ltd Co annual Income Tax Expense (Benefit) for 2020 was $11.8M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $5.86M $8.18M +$4.37M +115% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.49M -$35.5M -$3.96M -12.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $5.45M $33.9M -$3.95M -10.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 $9.41M -$758K +$18.5M +96.1% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-02
Q2 2022 -$9.14M $3.81M +$46.3M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$55.4M -$31.5M +$16.2M +34% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 -$71.7M $37.9M -$1.12M -2.87% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$70.5M -$19.3M +$71.8M +78.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$142M -$42.5M -$125M -151% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$16.9M -$47.8M -$28.7M -151% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $11.8M $39M +$595M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$583M -$91.1M -$60.5M -198% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$523M $83M +$87.8M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$610M -$19M -$17.1M -891% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$593M -$556M -$507M -1033% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$86.4M -$30.6M -$29.3M -2314% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 -$57.1M -$4.88M -$9.5M -205% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$47.6M -$1.92M -$2.87M -303% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$44.8M -$49.1M +$17.5M +26.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$62.2M -$1.27M -$8.45M -118% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$53.8M $4.62M +$6.39M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$60.2M $945K +$48.5M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$109M -$66.5M -$37.2M -127% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 -$71.4M $7.18M +$34.9M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$106M -$1.77M +$989K +35.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$107M -$47.6M -$46.1M -3195% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$61.3M -$29.3M +$6.15M +17.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 -$67.4M -$27.7M -$49.7M -226% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 -$17.7M -$2.76M +$158M +98.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$176M -$1.44M -$3.36M -175% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$172M -$35.5M -$32.6M -1159% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 -$140M $22M +$25M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$165M -$161M -$162M -18359% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$3.07M $1.91M +$3.02M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$6.08M -$2.82M -$2.66M -1729% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 -$3.42M -$3.04M -$3.31M -1248% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$114K $880K +$1.23M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$1.35M -$1.11M -$224K -25.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$1.12M -$154K +$182K +54.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 -$1.3M $265K +$4.78M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$6.08M -$351K -$192K -121% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$5.89M -$881K -$717K -437% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$5.17M -$336K +$13.8M +97.6% Oct 1, 2012 Dec 31, 2012 10-K/A 2015-03-02
Q3 2012 -$19M -$4.51M -$4.34M -2449% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 -$14.6M -$159K +$27K +14.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$14.7M -$164K +$18K +9.89% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$14.7M -$14.1M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 -$177K -$193K -1206% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$186K -$199K -1531% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-10
Q1 2011 -$182K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 $16K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $13K Apr 1, 2010 Jun 30, 2010 10-Q 2011-09-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.